XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive […]
